Cases exceeding the 90th percentile for dose, though infrequent, resulted in greater cumulative exposures for all cath lab staff.
Testing positive for recreational drugs at the time of admission with acute coronary syndrome was associated with increased ...
Intracoronary delivery of an injectable bioabsorbable alginate, known as the bioabsorbable cardiac matrix (BCM), does not decrease adverse left ventricular (LV) remodelling or cardiac events at 6 ...
Longer times from symptom onset to randomization equaled a smaller—or perhaps no—advantage for Impella vs standard care.
A new study finds that patients who suffer a STEMI heart attack while hospitalized are 10 times more likely to die than patients who suffer a STEMI outside the hospital. If you suffer a heart attack ...
Please provide your email address to receive an email when new articles are posted on . Long-term follow-up from DANAMI-3-PRIMULTI shows reduction in events after complete revascularization vs.
The Times Herald on MSN
Heart and stroke care gains McKenzie Health System national honors
McKenzie Health System earned two American Heart Association awards, credited with improving cardiac and stroke care in rural ...
Swapping out intravenous fentanyl in favor of IV acetaminophen in patients with ST-elevation MI (STEMI) provides comparable pain relief but with desirably higher blood levels of ticagrelor both ...
It's best to have patients on aggressive lipid-lowering therapy before discharge after an acute ST-segment elevation myocardial infarction (STEMI), so why not start it right away — even in the cath ...
Operators safely shaved a few minutes off heart attack reperfusion times by taking patients straight to culprit lesion percutaneous coronary intervention (PCI) when they arrived at the catheterization ...
Following cardiac catheterization, patients with ST-segment elevation myocardial infarction (STEMI) have a higher risk of short-term mortality than patients with non-STEMI (NSTEMI), who have a higher ...
A new study published in the journal of PloS One showed that although reoperative therapy with evolocumab with rosuvastatin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results